CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 88 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $603 | -99.9% | 103,300 | -1.4% | 0.03% | -14.7% |
| Q3 2022 | $702,000 | +59.2% | 104,800 | 0.0% | 0.03% | +78.9% |
| Q2 2022 | $441,000 | +14.5% | 104,800 | +228.5% | 0.02% | +137.5% |
| Q1 2019 | $385,000 | -76.2% | 31,900 | -75.3% | 0.01% | -77.1% |
| Q4 2018 | $1,621,000 | +0.3% | 129,206 | +18.6% | 0.04% | +20.7% |
| Q3 2018 | $1,616,000 | -9.3% | 108,912 | +2.8% | 0.03% | -6.5% |
| Q2 2018 | $1,782,000 | -28.4% | 105,942 | -2.5% | 0.03% | -27.9% |
| Q1 2018 | $2,489,000 | +572.7% | 108,652 | +658.8% | 0.04% | +616.7% |
| Q4 2017 | $370,000 | – | 14,318 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |